Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter M Andersen

Showing results (121-130 of 241) with videos related to

Pageof 25
Sort By:
Lakartidningen|October 4, 2008
[Changing neurology--from diagnostic to therapeutic discipline]Anja Smits, Gunnar Andsberg, Peter M Andersen, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|October 10, 2018
The Swedish motor neuron disease quality registryElisa Longinetti, Amanda Regodón Wallin, Kristin Samuelsson, et al.
BMC Palliative Care|December 30, 2017
Existential decision-making in a fatal progressive disease: how much do legal and medical frameworks matter?Christian Weber, Barbara Fijalkowska, Katarzyna Ciecwierska, et al.
Acta Neuropathologica|March 14, 2019
The molecular pathogenesis of superoxide dismutase 1-linked ALS is promoted by low oxygen tensionIsil Keskin, Elin Forsgren, Manuela Lehmann, et al.
Journal of Neurochemistry|February 10, 2026
N-Truncated Superoxide Dismutase-1 in Cerebrospinal Fluid Is Folded and ActiveLaura Leykam, Karin M E Forsberg, Peter M Andersen, et al.
Brain : a Journal of Neurology|August 13, 2014
Two novel mutations in conserved codons indicate that CHCHD10 is a gene associated with motor neuron diseaseKathrin Müller, Peter M Andersen, Annemarie Hübers, et al.
Journal of Neurology|November 21, 2013
Can lesions to the motor cortex induce amyotrophic lateral sclerosis?Angela Rosenbohm, Jan Kassubek, Patrick Weydt, et al.
Aging and Disease|April 24, 2019
Influence of Environment and Lifestyle on Incidence and Progress of Amyotrophic Lateral Sclerosis in A German ALS PopulationSonja Korner, Johanna Kammeyer, Antonia Zapf, et al.
Journal of Neurology|April 9, 2020
Impact of comorbidities and co-medication on disease onset and progression in a large German ALS patient groupKristin Diekmann, Magdalena Kuzma-Kozakiewicz, Maria Piotrkiewicz, et al.
Neurogenetics|June 6, 2007
Age at onset in sod1-mediated amyotrophic lateral sclerosis shows familialityIsabella Fogh, Fruhling Rijsdijk, Peter M Andersen, et al.
Pageof 25

Showing results (121-130 of 241) with videos related to

Sort By:
Pageof 25
Lakartidningen|October 4, 2008
[Changing neurology--from diagnostic to therapeutic discipline]Anja Smits, Gunnar Andsberg, Peter M Andersen, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|October 10, 2018
The Swedish motor neuron disease quality registryElisa Longinetti, Amanda Regodón Wallin, Kristin Samuelsson, et al.
BMC Palliative Care|December 30, 2017
Existential decision-making in a fatal progressive disease: how much do legal and medical frameworks matter?Christian Weber, Barbara Fijalkowska, Katarzyna Ciecwierska, et al.
Acta Neuropathologica|March 14, 2019
The molecular pathogenesis of superoxide dismutase 1-linked ALS is promoted by low oxygen tensionIsil Keskin, Elin Forsgren, Manuela Lehmann, et al.
Journal of Neurochemistry|February 10, 2026
N-Truncated Superoxide Dismutase-1 in Cerebrospinal Fluid Is Folded and ActiveLaura Leykam, Karin M E Forsberg, Peter M Andersen, et al.
Brain : a Journal of Neurology|August 13, 2014
Two novel mutations in conserved codons indicate that CHCHD10 is a gene associated with motor neuron diseaseKathrin Müller, Peter M Andersen, Annemarie Hübers, et al.
Journal of Neurology|November 21, 2013
Can lesions to the motor cortex induce amyotrophic lateral sclerosis?Angela Rosenbohm, Jan Kassubek, Patrick Weydt, et al.
Aging and Disease|April 24, 2019
Influence of Environment and Lifestyle on Incidence and Progress of Amyotrophic Lateral Sclerosis in A German ALS PopulationSonja Korner, Johanna Kammeyer, Antonia Zapf, et al.
Journal of Neurology|April 9, 2020
Impact of comorbidities and co-medication on disease onset and progression in a large German ALS patient groupKristin Diekmann, Magdalena Kuzma-Kozakiewicz, Maria Piotrkiewicz, et al.
Neurogenetics|June 6, 2007
Age at onset in sod1-mediated amyotrophic lateral sclerosis shows familialityIsabella Fogh, Fruhling Rijsdijk, Peter M Andersen, et al.
Pageof 25